SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Thursday reported a loss of $60.3 million in its fourth quarter.
The San Diego-based company said it had a loss of 73 cents per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.
The drug developer posted revenue of $74.8 million in the period, which topped Street forecasts. Seven analysts surveyed by Zacks expected $73.4 million.
For the year, the company reported a loss of $321.5 million, or $4.08 per share. Revenue was reported as $233.2 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVTX at https://www.zacks.com/ap/TVTX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
